Crit Rev Food Sci Nutr 58(5):741754
Glycemic control, pre-existing cardiovascular disease and risk of major cardiovascular events in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of cardiovascular outcome trials vs intensive glucose control trials
Clinical data shows the combination produces significantly greater weight loss than either agent alone
Once prescribed, semaglutide access is coordinated through regulated pharmacy channels associated with the MEDVi official website
Now, would there be patients with more mild disease, relatively more manageable disease who go on a GLP-1 and their psoriasis improves and they dont need a psoriasis treatment
Remember that Ozempic, Victoza, Trulicity, and Rybelsus are licensed for type 2 diabetes management, not weight loss, though weight reduction may occur as a beneficial side effect